SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?


To: Garth Richmond who wrote (211)1/9/1998 5:58:00 PM
From: George Mc Geary  Respond to of 1321
 
Garth, Yahoo has a time of 4:02 ET on the same article. Can't find anything on trading halted but there was no action in the last hour. Hope this is what this stock needed to keep its head above water. Now it will be a long time b4 we get approval BPD for AMD. George



To: Garth Richmond who wrote (211)1/9/1998 7:07:00 PM
From: Michael Anthony  Read Replies (3) | Respond to of 1321
 
The REALLY big news will be when Vertoprofin is approved for Age Related Macular Degeneration. I'm an optometrist. Trust me. The market there is bigger than all the other cancer stuff combined. When that's approved, you'll see major income. ARMD affects a huge amount of the elderly population. If the treatment is approved and covered by insurance, not only will it preserve sight that presently cannot be preserved, but we'll all make a ton on this stock. BTW, was it halted as of the close? I didn't see anything about a halt on quote.com.